Can the New Novavax Vaccine Deal With the New South African COVID Variant | Good Morning Britain

On Friday - Novavax; a jab trialled in the UK - was shown to be highly effective against the Kent variant in what the Health Secretary hailed as a “breakthrough”. The Novavax vaccine, which Vaccines Minister Nadhim Zahawi was himself injected with as part of the trial, was shown to be 89.3 per cent effective in preventing coronavirus in participants. The results will now be submitted to the Medicines and Healthcare products Regulatory Agency (MHRA) and if approved, the jab will become available for use in Britain alongside AstraZeneca, Pfizer and Moderna. Britain has already secured 60 million doses of the new vaccine, which will be produced at Stockton on Tees.

Subscribe now for more! http://bit.ly/1NbomQa

Broadcast on 02/02/2021

Like, follow and subscribe to Good Morning Britain!

The Good Morning Britain YouTube channel delivers you the news that you’re waking up to in the morning. From exclusive interviews with some of the biggest names in politics and showbiz to heartwarming human interest stories and unmissable watch again moments.

Join Susanna Reid, Piers Morgan, Ben Shephard, Kate Garraway, Charlotte Hawkins and Sean Fletcher every weekday on ITV from 6am until 9 every weekday!

ITV Hub: https://bit.ly/37kf3wD
Website: http://bit.ly/1GsZuha
YouTube: http://bit.ly/1Ecy0g1
Facebook: http://on.fb.me/1HEDRMb
Twitter: http://bit.ly/1xdLqU3

http://www.itv.com

#GMB #PiersMorgan #SusannaReid

Видео Can the New Novavax Vaccine Deal With the New South African COVID Variant | Good Morning Britain канала Good Morning Britain